AXGN News Alert Axogen Inc. (AXGN) 3.85 12/25/2014 05:40:53

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Axogen Inc. (AXGN) 3.85 $AXGN

Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
BRLI: 31.82 (+0.55), AXGN: 3.85 (+0.17), AZPN: 36.69 (+0.28), ARQL: 1.15 (+0.01), ADUS: 23.80 (-0.19)

AxoGen, Inc. Avance(R) Nerve Graft Recipient to be honored on Donate Life Rose Parade Float on New Year's Day
GlobeNewswire - Tue Dec 23, 6:02AM CST
via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a high-growth medical technology company with a unique and innovative portfolio of products used to repair injured peripheral nerves, announced that Shirley Pincus, one of the thousands of patients who have had injured nerves repaired with AxoGen's Avance(R) Nerve Graft, will be honored as a recipient of donated nerve tissue as a float rider in the 2015 Rose Parade aboard the Donate Life Rose Parade Float in Pasadena, California on New Year's Day.
AXGN: 3.85 (+0.17)

AxoGen, Inc. (AXGN) Jumps 5.45% on Insider Buying - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 8:18AM CST
AxoGen, Inc. (AXGN) was a big mover last session, as the company saw its shares rise by over 5% on the day.
AXGN: 3.85 (+0.17), AKRX: 36.47 (+0.43)

PDS Biotechnology, Inc. Announces Appointment of Biotech Industry Leader Sir Richard Sykes to its Board of Directors as Executive Chairman
PR Newswire Europe - Thu Dec 18, 9:41AM CST
PDS Biotechnology, a clinical stage immunotherapeutics company developing the powerful Versamune(R) nanoparticle technology, is delighted to announce that Sir Richard Sykes has accepted an invitation to join the company's board of directors as Executive Chairman.
AXGN: 3.85 (+0.17)

AxoGen perks up
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 8:22AM CST

AXGN: 3.85 (+0.17)

Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
BGFV: 14.46 (-0.12), AXGN: 3.85 (+0.17), BRK.B: 151.54 (-0.21), Y: 466.26 (-0.32), BIOD: 1.36 (-0.04)

Will AxoGen (AXGN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 8:05AM CST
Will AxoGen (AXGN) Continue to Surge Higher?
AXGN: 3.85 (+0.17)

AxoGen, Inc. CEO Karen Zaderej to Be Interviewed on Clear Channel - iHeart Business Talk Radio's "The Trader's Network" on December 2
GlobeNewswire - Tue Dec 02, 6:17AM CST
via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a high-growth medical technology company focused on the peripheral nerve repair market, announced today that Chief Executive Officer (CEO) Karen Zaderej will be interviewed live by host Michael Yorba on Clear Channel - iHeart Business Talk Radio's "The Trader's Network" Show. In this exclusive interview, Ms. Zaderej will discuss AxoGen's unique and innovative portfolio of peripheral nerve repair solutions that offer alternatives to the more than 900,000 patients each year who require surgical repair of an injured peripheral nerve. She will also discuss the Company's strong year-on-year growth and its strategy for becoming the market leader of the $1.6 billion peripheral nerve repair market in the US.
AXGN: 3.85 (+0.17)

AxoGen, Inc. CEO Karen Zaderej to Be Interviewed on Clear Channel -- iHeart Business Talk Radio's "The Trader's Network" on December 2nd, 2014
Marketwired - Tue Dec 02, 6:15AM CST
AxoGen, Inc. (NASDAQ: AXGN), a high-growth medical technology company focused on the peripheral nerve repair market, announced today that Chief Executive Officer (CEO) Karen Zaderej will be interviewed live by host Michael Yorba on Clear Channel -- iHeart Business Talk Radio's "The Trader's Network" Show. In this exclusive interview, Ms. Zaderej will discuss AxoGen's unique and innovative portfolio of peripheral nerve repair solutions that offer alternatives to the more than 900,000 patients each year who require surgical repair of an injured peripheral nerve. She will also discuss the Company's strong year-on-year growth and its strategy for becoming the market leader of the $1.6 billion peripheral nerve repair market in the US. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel's nationally syndicated iHeart Radio stream.
AXGN: 3.85 (+0.17)

AxoGen (AXGN) Looks Good: Stock Adds 5.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 8:46AM CST
AxoGen (AXGN) was a big mover last session, with shares rising nearly 6% on the day.
IPXL: 31.32 (+0.26), AXGN: 3.85 (+0.17), AKRX: 36.47 (+0.43), MYL: 56.97 (+0.39)

PDL BioPharma Announces Successful Conclusion of Revenue Interest Agreement with AxoGen
PR Newswire - Fri Nov 14, 6:00AM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company has received $30.3 million, in addition to previously received revenue interest payments, to conclude PDL's revenue interest agreement with AxoGen, Inc. (NASDAQ: AXGN). In October 2012, PDL entered into a structured financing transaction in which PDL provided AxoGen with an aggregate of $20.8 million in exchange for royalties on certain AxoGen revenues. AxoGen is a regenerative medicine company dedicated to advancing the science and commercialization of surgical solutions for peripheral nerve repair.
AXGN: 3.85 (+0.17), PDLI: 7.61 (unch)

AxoGen's (AXGN) CEO Karen Zaderej on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 7:19PM CST

AXGN: 3.85 (+0.17)

AxoGen beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 5:41PM CST

AXGN: 3.85 (+0.17)

AxoGen, Inc. Signs Agreement with Oberland Capital
GlobeNewswire - Thu Nov 13, 3:09PM CST
via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, has entered into a $28.55 million financing agreement with Three Peaks Capital S.a.r.l., an indirect wholly-owned subsidiary of Oberland Capital Healthcare Master Fund LP (collectively "Oberland" . The financing from Oberland, along with $1.75 million in capital from the Company, enables AxoGen to retire the Company's royalty agreement with PDL BioPharma, Inc. and substantially reduces AxoGen's future annual debt payments.
AXGN: 3.85 (+0.17), PDLI: 7.61 (unch)

AxoGen, Inc. Reports 58% Third Quarter Revenue Growth
GlobeNewswire - Thu Nov 13, 3:09PM CST
via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, grew revenue during the third quarter to $4.67 million, up 58% as compared to the year ago third quarter revenue of $2.96 million. The growth was driven by the successful execution of management's growth strategies, which are focused on increasing sales to existing customers and the addition of targeted new customers.
AXGN: 3.85 (+0.17)

AxoGen, Inc. to Report Third Quarter Financial Results on November 13, 2014
GlobeNewswire - Thu Nov 06, 6:09AM CST
via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, will report results for the third quarter ended September 30, 2014 on Thursday, November 13, 2014 after the market closes.
AXGN: 3.85 (+0.17)

AxoGen (AXGN) Shows Strength: Stock Up 15.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 8:39AM CDT
AxoGen, Inc. (AXGN) was a big mover last session, as its shares rose over 15% on the day.
MNK: 97.84 (-0.29), ACT: 254.20 (-1.68), AXGN: 3.85 (+0.17), MYL: 56.97 (+0.39)

AxoGen, Inc. Announces Presentation of Clinical Data for Avance(R) Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting
GlobeNewswire - Tue Sep 30, 6:05AM CDT
via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, announced the presentation of clinical data for Avance(R) Nerve Graft during the American Society for Surgery of the Hand (ASSH) 2014 Annual Meeting which took place last week in Boston.
AXGN: 3.85 (+0.17)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 67

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 65

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 23

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 99

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 104

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Protein Now! Gains Clinician Attention, With Caveats

Updated Category News Views 91

A Small Bottle Has Drawn a Crowd Protein powder tubs have been cluttering kitchens for years; a 3.38-fluid-ounce shot is a cleaner answer to the same daily hassle. NutraBio Labs says more than 800 physicians, nurse practitioners, and physician associates had added PROTEIN NOW! to their individual FrontrowMD patient pages as of November 2026. That earned the product a...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 14

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Africa Tech Festival Puts Trust Ahead of AI Hype Cycle

Updated Category News Views 75

Fifteen thousand people can fill a convention centre, but they cannot magically deliver a package, fund a small business, or repair harm from a bad automated decision. That rather useful dose of reality ran through the final day of Africa Tech Festival 2026 in Cape Town. The 29th edition drew more than 15,000 delegates across three days, and the strongest message was not...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 113

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading

Top 5 Most Recently Viewed Articles

ICG Enterprise Trust plc Announces Share Repurchase Details

Updated Category News Views 159

ICG Enterprise Trust plc Share Buyback Announcement ICG Enterprise Trust plc (the “Company”) The Company has announced a recent development regarding its share buyback initiative. On a significant date, it repurchased 15,000 of its own shares aimed to be held as treasury shares, with each share valued at an average price of 1450 pence. Details of the Transaction...

Continue Reading
Converge Technology Solutions Shares Third Quarter 2024 Insights

Updated Category News Views 217

Converge Technology Solutions Announces Preliminary Q3 Results Converge Technology Solutions Corp. (CTS) has released its preliminary unaudited financial results for the third quarter of 2024. The company is committed to delivering insightful updates to its stakeholders as part of its transparency approach. The company stated that all figures are presented in Canadian...

Continue Reading
Discovery Silver Corp. Unveils 2023 ESG Report

Updated Category News Views 104

Discovery Silver Corp. Releases 2023 ESG Report Key Highlights: Earned Quality Environmental Certification from the Mexican Government Recognized as a Socially Responsible Enterprise by the Mexican Center for Philanthropy Achieved Great Place to Work Certification Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) is excited to announce the publication of its 2023...

Continue Reading
Final Call for Subscription in IDEX Biometrics Offering Today

Updated Category News Views 152

Important Subscription Period Details for IDEX Biometrics Today marks a significant turning point for IDEX Biometrics ASA as the subscription period for their subsequent offering of shares closes. The company previously announced that they aim to issue up to 600 million new shares at a remarkable subscription price of NOK 0.01 per share. This offering, essential for...

Continue Reading
Dundee Corporation Strengthens Position in Greenheart Gold Inc.

Updated Category News Views 33

Overview of Recent Acquisition Dundee Corporation (TSX: DC.A) has announced that its wholly-owned subsidiary, Dundee Resources Limited, recently acquired 2,000,000 common shares of Greenheart Gold Inc. (TSXV: GHRT) at a price of C$0.50 per share, totaling an investment of C$1,000,000. This acquisition is part of the Issuer's bought deal private placement and signifies...

Continue Reading